Vir Biotechnology, Inc.

SEC 4 · Filed

0001628280-26-012394Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 25, 2026

Sale by Eisner Mark

Security
Common Stock
Code
S
Shares
1,889
Price per share
9.82
Structured facts
{
  "code": "S",
  "date": "2026-02-25",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025."
  },
  "owners": [
    {
      "cik": "0001834161",
      "name": "Eisner Mark",
      "roles": [
        "officer"
      ],
      "title": "EVP and Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "154024",
  "price": "9.82",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1889",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 24, 2026

Sale by Eisner Mark

Security
Common Stock
Code
S
Shares
1,616
Price per share
9.53Reported 9.5326
Structured facts
{
  "code": "S",
  "date": "2026-02-24",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer\u0027s tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."
  },
  "owners": [
    {
      "cik": "0001834161",
      "name": "Eisner Mark",
      "roles": [
        "officer"
      ],
      "title": "EVP and Chief Medical Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "155913",
  "price": "9.5326",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1616",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}